New Directions in the Treatment of Non-Muscle Invasive Bladder Cancer

Experts provide an overview of non-muscle invasive bladder cancer (NMIBC) and common procedures for diagnosis.

Experts discuss the variability of non-muscle invasive bladder cancer (NMIBC) in terms of staging and risk stratification and how they navigate these diagnoses with their patients.

Experts discuss the evolving landscape of chemotherapy and immunotherapy options for patients with non-muscle invasive bladder cancer (NMIBC).

Experts discuss current trial data from several studies on non-muscle invasive bladder cancer (NMIBC).

Experts consider other pipeline treatments for non-muscle invasive bladder cancer (NMIBC), including new injectable options being explored.

Experts discuss logistical considerations when providing the best treatment to patients with non-muscle invasive bladder cancer (NMIBC).

Experts discuss the mental impact of non-muscle invasive bladder cancer (NMIBC) treatment and approaches for developing a care network for those patients.

Experts conclude their discussion on non-muscle invasive bladder cancer (NMIBC) highlighting practice considerations for today and the future.